CORPORATE
GIVING

. .

.
READ MORE

SUSTAINABILITY AT EDWARDS

We welcome you to review our sustainability report

READ MORE

LEARN MORE ABOUT 
AORTIC STENOSIS

at newheartvalve.com 
.

READ MORE

CORPORATE
GIVING

. .

.
READ MORE

SUSTAINABILITY AT EDWARDS

We welcome you to review our sustainability report

READ MORE

LEARN MORE ABOUT
AORTIC STENOSIS

at newheartvalve.com

READ MORE

Corporate
Giving .

Learn More

Our commitment to charitable giving and participation in philanthropic causes is one of the defining elements of Edwards Lifesciences’ culture.

Sustainability
at Edwards

Aortic
Stenosis

1958

Lowell Edwards dreams of creating an artificial heart

1960

First successful mitral valve replacement using the Starr-Edwards Silastic ball valve

 
1961

Edwards Laboratories established in Orange County, CA

1963

Development of the Fogarty embolectomy catheter spawns Edwards’ Vascular business

1970

Development of the Swan-Ganz catheter spawns Edwards’ Critical Care business

1975

Carpentier-Edwards porcine bioprostheses launch

1981

Carpentier-Edwards PERIMOUNT pericardial bioprostheses introduced

1993

Carpentier-Edwards Physio annuloplasty ring introduced

1993

Introduction of the Vigilance monitor

2000

Edwards Lifesciences spins off from Baxter and trades on the NYSE: EW

2000

Grand opening of Haina, Dominican Republic manufacturing facility

2004

Edwards acquires Percutaneous Valve Technologies

2005

Introduction of FloTrac minimally invasive hemodynamic monitoring technology

2007

Edwards SAPIEN transcatheter heart valve introduced in Europe

2008

Grand opening of Singapore heart valve manufacturing facility

2010

Edwards SAPIEN XT transcatheter heart valve introduced in Europe

2010

Grand opening of Draper, Utah manufacturing facility

2010

EV1000 and VolumeView monitoring technologies introduced in Europe

2011

Edwards SAPIEN transcatheter heart valve introduced in the U.S.

2012

ThruPort systems for MIVS introduced worldwide

2012

EDWARDS INTUITY valve system introduced in Europe

*not available for commercial sale in the U.S.

2013

Edwards SAPIEN XT transcatheter heart valve introduced in Japan

2013

ClearSight noninvasive monitoring system approved in Europe

2014

Edwards SAPIEN 3 transcatheter heart valve introduced in Europe

2014

EDWARDS INTUITY ELITE valve system introduced in Europe

*not available for commercial sale in the U.S.

2014

ClearSight noninvasive monitoring system approved in the U.S.

2014

Edwards SAPIEN XT transcatheter heart valve introduced in the U.S.

2015

Edwards SAPIEN 3 transcatheter heart valve introduced in the U.S.

1958

Lowell Edwards dreams of creating an artificial heart

1960

First successful mitral valve replacement using the Starr-Edwards Silastic ball valve

 
1961

Edwards Laboratories established in Orange County, CA

1963

Development of the Fogarty embolectomy catheter spawns Edwards’ Vascular business

1970

Development of the Swan-Ganz catheter spawns Edwards’ Critical Care business

1975

Carpentier-Edwards porcine bioprostheses launch

1981

Carpentier-Edwards PERIMOUNT pericardial bioprostheses introduced

1993

Carpentier-Edwards Physio annuloplasty ring introduced

1993

Introduction of the Vigilance monitor

2000

Edwards Lifesciences spins off from Baxter and trades on the NYSE: EW

2000

Grand opening of Haina, Dominican Republic manufacturing facility

2004

Edwards acquires Percutaneous Valve Technologies

2005

Introduction of FloTrac minimally invasive hemodynamic monitoring technology

2007

Edwards SAPIEN transcatheter heart valve introduced in Europe

2008

Grand opening of Singapore heart valve manufacturing facility

2010

Edwards SAPIEN XT transcatheter heart valve introduced in Europe

2010

Grand opening of Draper, Utah manufacturing facility

2010

EV1000 and VolumeView monitoring technologies introduced in Europe

2011

Edwards SAPIEN transcatheter heart valve introduced in the U.S.

2012

ThruPort systems for MIVS introduced worldwide

2012

EDWARDS INTUITY valve system introduced in Europe

*not available for commercial sale in the U.S.

2013

Edwards SAPIEN XT transcatheter heart valve introduced in Japan

2013

ClearSight noninvasive monitoring system approved in Europe

2014

Edwards SAPIEN 3 transcatheter heart valve introduced in Europe

2014

EDWARDS INTUITY ELITE valve system introduced in Europe

*not available for commercial sale in the U.S.

2014

ClearSight noninvasive monitoring system approved in the U.S.

2014

Edwards SAPIEN XT transcatheter heart valve introduced in the U.S.

2015

Edwards SAPIEN 3 transcatheter heart valve introduced in the U.S.

Please update your browser

Please update to a current version of your preferred browser, this site will perform effectively on the following:

Unable to update your browser?

If you are on a computer, that is maintained by an admin and you cannot install a new browser, ask your admin about it. If you can't change your browser because of compatibility issues, think about installing a second browser for browsing and keep this old one for compatibility